Literature DB >> 9746032

Relief by botulinum toxin of voiding dysfunction due to prostatitis.

G Maria, A Destito, S Lacquaniti, A R Bentivoglio, G Brisinda, A Albanese.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9746032     DOI： 10.1016/S0140-6736(05)79580-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 2.  Botox in urology.

Authors:  Ali Thwaini; Iqbal Shergill; Suresh Radhakrishnan; Frank Chinegwundoh; Hadeel Thwaini
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-11-19

Review 3.  Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxin.

Authors:  Abdel-Rahmène Azzouzi; Marc Fourmarier; Francois Desgrandchamps; Charles Ballereau; Christian Saussine; Olivier Haillot; Bertrand Lukacs; Marian Devonec; Alexandre de la Taille
Journal:  World J Urol       Date:  2006-05-18       Impact factor: 4.226

Review 4.  A review of botulinum toxin use for chronic pelvic pain syndrome.

Authors:  Henry P Gottsch; Claire C Yang; Richard E Berger
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 5.  Management of bladder, prostatic and pelvic floor disorders.

Authors:  G Brisinda; G Maria; A R Bentivoglio; F Cadeddu; G Marniga; F Brandara; A Albanese
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 6.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

Review 7.  Minimally invasive therapies for prostatitis.

Authors:  Peter Zvara; Jeffrey B Folsom; Mark K Plante
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

Review 8.  Advanced therapy for prostatitis: minimally invasive and invasive therapies.

Authors:  Assaad El-Hakim; Darshan K Shah; Arthur D Smith
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 9.  Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2015-06-18       Impact factor: 4.546

10.  Intraprostatic injection of botulinum toxin-A in patients with refractory chronic pelvic pain syndrome: The transurethral vs. transrectal approach.

Authors:  Mohamed A El-Enen; Mohamed Abou-Farha; Ahmed El-Abd; Hassan El-Tatawy; Ahmed Tawfik; Shawky El-Abd; Mohamed Rashed; Mahmoud El-Sharaby
Journal:  Arab J Urol       Date:  2015-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.